Patents by Inventor Chantal Appeldoorn

Chantal Appeldoorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070185348
    Abstract: P-selectin targeting ligand molecules are provided as well as compositions, including kits, which comprise such P-selectin targeting ligand molecules, such composition being useful for use as pharmaceutical formulations which can be administered safely and effectively and as diagnostic formulations.
    Type: Application
    Filed: June 1, 2004
    Publication date: August 9, 2007
    Applicant: Astellas Pharma Inc.
    Inventors: Chantal Appeldoorn, Theodorus Van Berkel, Erik Leonardus
  • Publication number: 20060276545
    Abstract: Polyhydroxy phenols, which are non-peptidic mimetics of galloyl peptides, and a process for the preparation of gallic acid derivatives using a gallic-acid providing moiety are provided as well as polyhydroxy phenol-containing pharmaceutical and nutraceutical compositions. The use of polyhydroxy phenols as a medicament and especially for the manufacture of a medicament for the prevention, treatment or diagnosis of a disease or a condition, wherein P-selectin is involved, is provided. The same compounds can also be used as targeting tools to P-selectin expressing cells or tissues in a composition, further comprising an active compound in a vehicle.
    Type: Application
    Filed: May 7, 2004
    Publication date: December 7, 2006
    Applicant: YAMANOUCHI PHARMACEUTICAL CO., LTD.
    Inventors: Erik Anna Biessen, Chantal Appeldoorn, Arnaud Bonnefoy, Theodorus Van Berkel, Johan Kuiper, Marc Hoylaerts
  • Publication number: 20060217294
    Abstract: The present invention relates to derivatives of compounds which bind selectively to the adhesion molecule human P-selectin, and particularly to such derivatives which comprise a peptide moiety or a functional equivalent of said peptide moiety and are represented by X(Ax)mA3A1A2A1Y. In addition, the invention relates to methods for preparing such compounds, to the use of such compounds in therapeutic or diagnostic methods and in pharmaceutical compositions, to binding molecules binding to said compounds and to a method for determining whether a compound is capable of binding to P-selectin.
    Type: Application
    Filed: July 4, 2003
    Publication date: September 28, 2006
    Inventors: Chantal Appeldoorn, Erik Anna Biessen, Thomas Molenaar, Johan Kuiper, Theodorus Van Berkel
  • Publication number: 20050261207
    Abstract: The present invention relates to certain glucose-based compounds that have an affinity to P-selectin. Further, the invention relates to the use of these glucose-based compounds for the preparation of pharmaceutical compositions for the treatment of disorders associated with P-selectin, to conjugates, pharmaceutical carriers and drug delivery systems comprising said compounds, and to a method for determining whether a compound is capable of binding to P-selectin.
    Type: Application
    Filed: October 13, 2003
    Publication date: November 24, 2005
    Applicant: Yamanouchi Europe B.V.
    Inventors: Chantal Appeldoorn, Erik Biessen, Thomas Molenaar, Theodorus Josephus Van Berkel